Unlike standard two-tier protocols, the assay uses a dual-antigen binding approach to improve early detection accuracy and may offer a more efficient workflow for clinical labs
Study also identifies biocides that work well against Psedomonas aeruginosa
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.